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Autoinhibition is a recurring mode of protein kinase
regulation and can be based on diverse molecular mechan-
isms. Here, we show by crystal structure analysis, nuclear
magnetic resonance (NMR)-based nucleotide affinity stu-
dies and rational mutagenesis that nonphosphorylated
mitogen-activated protein (MAP) kinases interacting ki-
nase (Mnk) 1 is autoinhibited by conversion of the activa-
tion segment into an autoinhibitory module. In a Mnk1
crystal structure, the activation segment is repositioned
via a Mnk-specific sequence insertion at the N-terminal
lobe with the following consequences: (i) the peptide
substrate binding site is deconstructed, (ii) the interlobal
cleft is narrowed, (iii) an essential Lys–Glu pair is dis-
rupted and (iv) the magnesium-binding loop is locked into
an ATP-competitive conformation. Consistently, deletion
of the Mnk-specific insertion or removal of a conserved
phenylalanine side chain, which induces a blockade of the
ATP pocket, increase the ATP affinity of Mnk1. Structural
rearrangements required for the activation of Mnks are
apparent from the cocrystal structure of a Mnk2D228G–
staurosporine complex and can be modeled on the basis
of crystal packing interactions. Our data suggest a novel
regulatory mechanism specific for the Mnk subfamily.
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Introduction
Mitogen-activated protein (MAP) kinases interacting kinases
(Mnks) phosphorylate the eukaryotic translation initiation
factor 4E (eIF4E) (Waskiewicz et al, 1997, 1999; Scheper
et al, 2001) and factors that bind to AU-rich elements in the
30-untranslated region of certain mRNAs (Buxade et al, 2005).
Via these activities, Mnks apparently regulate the expression
of a specific set of proteins (Nikolcheva et al, 2002; Walsh
and Mohr, 2004; Buxade et al, 2005) rather than global
protein synthesis (O’Loghlen et al, 2004b; Ueda et al, 2004;
Reiling et al, 2005). Mnks are involved in growth control
(Reiling et al, 2005), inflammation (Nikolcheva et al, 2002;
Buxade et al, 2005) and viral translation (Walsh and
Mohr, 2004) and, therefore, represent interesting targets for
pharmaceutical intervention.
Mnks comprise a subfamily of Ser/Thr kinases (Manning
et al, 2002). Phylogenetically they are placed into the group of
Ca2þ/calmodulin-dependent kinases (CaMK) (Manning et al,
2002), although, like many other CaMK group members,
they are not regulated by Ca2þ/calmodulin (Slentz-Kesler
et al, 2000). Mnks are activated through phosphorylation by
the growth factor-stimulated Ras/extracellular signal-regu-
lated kinase pathway and the stress-induced p38 pathway
(Fukunaga and Hunter, 1997; Waskiewicz et al, 1997). There
are two human Mnk genes, mnk1 and mnk2, each of which
gives rise to alternatively spliced isoforms (Mnk1a, Mnk1b,
Mnk2a and Mnk2b) spanning 347–465 residues (Scheper
et al, 2003; O’Loghlen et al, 2004a). All four proteins bear
a stretch of basic residues at their N-termini that functions
as a nuclear localization signal and as a binding region for the
eukaryotic initiation factor 4G. Mnk1a and Mnk2a contain
putative nuclear export motifs and MAP kinase-binding sites
C-terminal of the central kinase domains, both of which
are removed by alternative splicing in Mnk1b and Mnk2b.
Here, we investigated the catalytic domains of Mnk1 and
Mnk2, which are B80% sequence identical and are not
affected by alternative splicing.
The catalytic domains of protein kinases (PKs) encompass
conserved structural elements for binding of ATP and the
peptide substrates and for phosphoryl transfer. Therefore, the
structures of active-state PKs closely resemble each other,
whereas the structures of inactive-state kinases are diverse
(Huse and Kuriyan, 2002; Nolen et al, 2004). Tight control of
PK activities is essential for intracellular signaling cascades.
Switching between inactive and active PK conformations can
be achieved by diverse mechanisms, such as phosphoryla-
tion/dephosphorylation (Canagarajah et al, 1997; Krupa et al,
2004), release/binding of autoinhibiting domains (Goldberg
et al, 1996; Kobe et al, 1996; Mol et al, 2004a) and inter-
action with regulatory subunits (Jeffrey et al, 1995) or by
a combination of these strategies (Russo et al, 1996).
Consequently, there is no generic molecular mechanism for
inactivating PKs. Yet, it is crucial for the development of
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specific inhibitors to understand the regulation of individual
kinases in detail.
We have recently reported the crystal structure of the
nonphosphorylated Mnk2 catalytic domain (Jauch et al,
2005), in which the enzyme exhibited a noncanonical
extended arrangement of the activation segment and an
ATP-competitive conformation of the magnesium-binding
Asp-Phe-Asp (DFD) motif. The latter motif is conserved as
an Asp-Phe-Gly (DFG) sequence in other kinases. The sig-
nificance of the extended activation segment and the reason
why the protein prefers the inhibitory DFD motif conforma-
tion remained elusive. Here, we present the crystal structures
of the Mnk1 catalytic domain and of a Mnk2 active site
mutant in complex with staurosporine, which provide an
explanation for this architecture. Our results reveal that
in nonphosphorylated Mnk1 the activation segment is
converted into an autoinhibitory module. Autoinhibition
encompasses impaired ATP binding and peptide substrate
positioning, primarily mediated by a Mnk-specific sequence
insertion within the activation segment. Solution nuclear
magnetic resonance (NMR) studies on wild-type (wt) and
mutant enzymes together with homology modeling and struc-
tural comparisons support this mode of autoinhibition in
Mnk1 and suggest that Mnk2 is autoinhibited by a similar
mechanism. The ensemble of Mnk structures now available
highlight structural transitions accompanying Mnk activation.
Results
Overall architecture of the Mnk1 catalytic domain
We produced a polypeptide spanning residues 37–341 of
Mnk1 in Escherichia coli and purified it to homogeneity.
It includes the catalytic domain of Mnk1 and is henceforth
referred to as Mnk1-kinase region (Mnk1-KR). Similarly to
Mnk2-KR (Jauch et al, 2005), this fragment recapitulates the
activity of the full-length protein in that it phosphorylates an
eIF4E peptide only after activation by ERK2 in vitro (data not
shown). Mnk1-KR could be crystallized and the structure
could be solved and refined to 2.8 A˚ resolution, including
anisotropic data to 2.5 A˚ resolution (Table I). The asymmetric
unit contains two Mnk1-KR molecules related by a noncrys-
tallographic two-fold axis. Although one molecule exhibits
lower temperature factors and a clearer electron density
in several regions, the functionally important regions are
virtually identical in both molecules. The final model
encompasses residues 39–335 of Mnk1.
Mnk1-KR displays the bilobal makeup of PKs (Knighton
et al, 1991). The N-terminal lobe contains a twisted sheet of
five antiparallel b-strands (b1–b5) and the regulatory helix aC
(Figures 1 and 2A). It harbors the elements essential for ATP
binding such as the glycine-rich loop (GR-loop), a conserved
Lys78 in strand b3 and a conserved Glu94 in helix aC. The
predominantly a-helical C-terminal lobe contains the ele-
ments required for peptide substrate binding and phosphate
transfer, including the catalytic loop (C-loop, residues 170–
175 in Mnk1), the magnesium-binding loop, and the activa-
tion segment (residues 194–235; Figures 1 and 2A). The
magnesium-binding loop of Mnks contains a noncanonical
DFD motif (residues 191–193 in Mnk1) instead of the other-
wise highly conserved DFG motif (Hanks et al, 1988; Taylor
and Radzio-Andzelm, 1994; Hanks, 2003). Two sections of
the Mnk1-KR exhibit extensive conformational flexibility and
could not be traced in the electron density. First, the core of
the activation segment including the activation loop and the
Pþ 1 loop (residues 197–222) and second, a region encom-
passing helix aG (residues 261–290), which has been shown
to comprise a Zn2þ -coordinating motif in Mnk2 (Jauch et al,
2005), possibly involved in substrate binding (Dar et al,
2005). In the present structure, the Zn2þ -binding site may
be disordered owing to a lack of crystal packing interactions
that stabilized the motif in Mnk2-KR crystals. Although
we could not detect Zn2þ in the Mnk1-KR crystals by X-ray
fluorescence (not shown), the high conservation of four
cysteines in the latter region suggests that the Zn2þ -binding
site is a general feature of Mnks. Zn2þ binding may be
stabilized by interacting factors in vivo.
The activation segment is repositioned
at the N-terminal lobe
In active PKs, the Pþ 1 loop and the following helix aEF are
buried within the kinase core in an environment provided by




Space group P43212 P3221
Cell dimensions
a, b, c (A˚) 93.5, 93.5, 175.2 102.4, 102.4, 76.4
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Sulfate ions 2 —
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tensity of the ith measurement of hkl; /I(hkl)S—average value of
hkl for all i measurements.
bData up to 2.5 A˚ resolution have been included in the refinement.
Statistics for data between 2.8 and 2.5 A˚ resolution: Rsym—34.9 %;
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Figure 1 Sequence comparison. Multiple sequence alignment of Mnk1, Mnk2, DAPK1, Flt3 (SwissProt ID P36888) and c-KIT (NCBI entry code
NP000222) spanning the kinase domains. The DAPK1-Mn2þ -AMPPNP cocrystal structure (Tereshko et al, 2001) represents a CaMK group
member in the active state. c-KIT (Mol et al, 2004b) and Flt3 (Griffith et al, 2004) are receptor tyrosine kinases, in which autoinhibition via an
N-terminal JM domain (not shown) resembles autoinhibition via the activation segment in Mnk1 (see Discussion). The alignment was made
with T-Coffee (Notredame et al, 2000), shaded with BoxShade (http://www.ch.embnet.org/software/BOX_form.html) and edited manually.
A darker background indicates a higher conservation. Functional elements are color-coded and labeled: tip of the glycine-rich loop (GR-loop)—
cyan; Lys–Glu ion pair—magenta; helix aC—blue; catalytic loop (C-loop)—yellow; DFG/D motif—orange; activation segment—green. This
coloring scheme is maintained in the following structure figures. The background of the conserved Lys–Glu pair is shown in magenta, the
background of the Mnk-specific Phe230/Phe265 (Mnk1/Mnk2) of the activation segment in green. Insertions that are specific for Mnks within
the CaMK group (I1–I3) are boxed. The hinge region separates the N- and C-terminal lobes as indicated. Phosphorylation sites are shown in red
(labeled ‘P’). Secondary structure elements as found in Mnk1-KR (this work) and Mnk2-KR (Jauch et al, 2005) (PDB-ID 2AC3) are given below
the alignment (Mnk1—black, Mnk2—gray). Note that in this and the following figures, we refer to the Mnk-specific activation segment, which
is expanded and includes aEF and the aEF/aF loop (see the text for details).
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the C-loop and helices aF and aG (Knighton et al, 1991). In
this position, the Pþ 1 loop can interact with the peptide
substrate at the residue following the phosphorylation site.
The short helix aEF is connected to helix aF through the aEF/
aF loop, which varies in size and sequence among different
PKs (Nolen et al, 2004). In Mnk1-KR, helix aEF, designated by
the highly conserved Ala-Pro-Glu (APE) motif, is unwound.
The region corresponding to aEF and the aEF/aF loop is
detached from the C-terminal lobe and traverses the inter-
lobal cleft (Figures 2A and 3A). The APE motif and residues
from the aEF/aF loop line up with helix aC at the N-terminal
lobe (Figures 2A and 3A). As a consequence, the N-terminal
lobe is displaced towards the C-terminal lobe and there-
by narrows the interlobal cleft (Figure 2A and B). Further-
more, repositioning of the aEF-aEF/aF loop region demands
that the Pþ 1 loop be concomitantly disengaged from the
C-terminal lobe, impairing the peptide substrate-binding site.
Hence, the current positioning of the Pþ 1 loop and the helix
aEF-aEF/aF loop region is incompatible with kinase activity.
The activation segment of Mnk1 is reorganized
The ‘activation segment’ of a PK traditionally refers to the
section delineated by the DFG and APE motifs. At its core, the
‘activation loop’ designates the region typically undergoing
structural reorganization upon activation/inactivation (Nolen
et al, 2004). In Mnk1-KR, however, the region subjected to
structural reorganization extends to aEF and the aEF/aF loop
(Figures 1, 2A and 3A). Thus, the Mnk-specific activation
segment is expanded and includes, in contrast to previous
conventions (Nolen et al, 2004), aEF and the aEF/aF loop. The
structure of Mnk1-KR therefore represents the most extensive
rearrangement of an activation segment reported to date.
The inhibitory conformation of the activation segment in
Mnk1-KR likely reflects structural consequences of an amino-
acid insertion (I2; Figure 1) within the aEF/aF loop. I2 is
conserved in Mnks but is absent from other CaMK group PKs
(Figure 1). Residues of insertion I2 are instrumental in
stabilizing the autoinhibitory conformation seen in Mnk1-
KR (e.g. Glu228 and Phe230; see below). Thus, in nonphos-
phorylated Mnk1-KR, insertion I2 constitutes a key determinant
leading to the reprogramming of the activation segment into
an autoinhibitory module. Another Mnk-specific insertion
(I1) is located C-terminal of the DFD motif and is disordered
in the present structure.
Phosphate-binding residues stabilize the autoinhibited
structure
The inactive conformation of nonphosphorylated Mnk1-KR is
stabilized by ionic interactions involving conserved Arg
residues. First, Arg90 and Arg93 from helix aC contact
Glu225 (APE motif) and Glu228 (aEF/aF loop), respectively,
thereby fastening the activation segment to the N-terminal
lobe (Figure 3C). Second, Arg169 upstream of the catalytic
loop (the RD-Arg) forms an ion pair with Asp238
(not shown). The RD-Arg and the Arg residues from helix
aC are known to form the so-called RD-pocket, which in
activated PKs accommodates phosphorylated residues from
the activation segment (Krupa et al, 2004; Nolen et al, 2004).
The interaction between such phosphorylated residues and
the RD-pocket correctly positions the activation segment for
substrate binding at the C-terminal lobe (Nolen et al, 2004).
Thus, the phosphate groups introduced during activation will
provide alternative interaction sites for the RD-pocket resi-
dues, most likely leading to a disruption of the intramolecular
interactions seen in Mnk1-KR and thereby releasing the
activation segment from the N-terminal lobe.
The repositioned activation segment locks
an ATP-competitive conformation
The first Asp of the DFG motif at the beginning of the
activation segment is invariant among catalytically active
PKs and is known to coordinate a magnesium ion that is
essential for phosphoryl transfer (Adams, 2001). The region
encompassing the DFG motif has therefore been termed the
magnesium-binding loop. Mnks contain a DFD motif at
the corresponding positions. In active kinases, the Phe of
the DFG/D motif is situated in a pocket, which in Mnk1-KR is
provided by Thr97 and Leu98 (emanating from helix aC),
His168 (upstream of the C-loop), Ile107, Leu161 and Ile189.
This active DFG/D motif conformation is referred to as DFG/
D-in and its corresponding binding site will henceforth be
referred to as DFG/D-in pocket.
The conformation of the activation segment in the present
Mnk1-KR structure has a pronounced effect on the DFD
motif. Phe230, which emanates from the Mnk-specific
aEF/aF loop insertion I2 and is conserved in the Mnk
subfamily (Figure 1), comes to lie in the DFG/D-in pocket
(Figures 3A and C). It thereby displaces the DFD motif, which
in turn is rotated by B1801 around the F angle of Asp191
(FAsp191¼1101) with respect to the DFG/D-in conform-
ation of active-state PKs (FAsp191, DAPK1¼ 551) (Tereshko
et al, 2001). Phe192 of the DFD motif, in turn, occupies a
hydrophobic pocket provided by Val63, Leu108, Phe124 (the
‘gatekeeper residue’) and Leu177, which would normally
accommodate the adenosyl moiety of ATP. The resulting
DFD conformation is referred to as DFG/D-out and is incom-
patible with ATP binding.
The Mnk-specific DFD stabilizes the DFG/D-out
conformation
The DFG/D-out conformation in Mnk1-KR is stabilized by a
network of unconventional interactions. Both, the invariant
Asp191 and the Mnk-specific Asp193 of the DFD motif are
engaged in tight carboxyl–carboxyl side chain interactions
with the active site residues Glu94 and Asp170, respectively
(Figure 4A). The two contacting oxygens of the carboxylate
groups are 2.5–2.6 A˚ apart in both instances, which is
significantly shorter than the average O–O distance in
nonacidic hydrogen bonds (Flocco and Mowbray, 1995).
These arrangements suggest that the interacting carboxylates
are partially protonated. As described for other such carboxyl–
carboxyl interactions (Werten et al, 2002), the Asp191–Glu94
and Asp193–Asp170 pairs are stabilized by neigh-
boring amines (Lys78) or amides (Asn175), respectively
(Figure 4A). Attractive carboxyl–carboxyl side chain inter-
actions are often observed in protein structures and are
particularly abundant within the catalytic centers of enzymes
(Flocco and Mowbray, 1995).
Glu94 and Asp170 correspond to residues that are invar-
iant among catalytically active PKs (Hanks et al, 1988). Glu94
originates from the regulatory helix aC and is known to
form an ion pair with Lys78 that is essential for productive
ATP binding (Adams, 2001). This pairing is obstructed in
Mnk1-KR, because Asp191 of the DFD motif is wedged
Autoinhibition in Mnks
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between Glu94 and Lys78 (Figure 4A). Asp170 corresponds
to the catalytic Asp residue of the C-loop (Figure 4A).
Comparison of Mnk1-KR and Mnk2-KR crystal structures
Recently, we have reported the crystal structure of Mnk2-KR
(Jauch et al, 2005). Mnk1 and Mnk2 exhibit 78% sequence
identity within their catalytic domains, both enzymes
are activated by similar cellular stimuli and their reported
substrate specificities are identical (Waskiewicz et al, 1999;
Scheper et al, 2001). It is therefore surprising that the crystal
structures of Mnk1-KR and Mnk2-KR exhibit pronounced
differences in the relative orientations of the lobes, in the
conformations of the activation segments and in atomic
details of the DFG/D-out conformations (Figures 2A, B and
Figure 3 Autoinhibitory conformation of the activation segment. (A) Ribbon plot of Mnk1-KR. A region corresponding to helix aEF and the
aEF/aF loop traverses the interlobal cleft from the N- to the C-terminal lobe (direction: green arrow). Phe230 (ball-and-stick) of the Mnk-
specific insertion I2 in the activation segment occupies the DFG/D-in pocket, thereby pushing Phe192 (ball-and-stick) of the DFD motif into the
ATP-binding pocket. (B) Ribbon plot of c-KIT (Mol et al, 2004b) (PDB ID 1T45). The autoinhibitory JM domain is shown in red. It crosses the
interlobal cleft from the N- to the C-terminal lobe (red arrow). Trp557 (ball-and-stick) of the JM domain is mechanistically analogous to Phe230
in Mnk1-KR. The activation segment of c-KIT is fully visible in contrast to Mnk1-KR. (C) Close-up stereo ribbon plot showing the activation
segment of Mnk1-KR folding back across the interlobal cleft and lining up with helix aC. The activation segment and interacting residues are
shown in ball-and-stick. Hydrogen bonds and salt bridges that tether the activation segment are shown as dashed lines. Two Arg residues of
helix aC and two interacting Glu residues of the activation segment are labeled. The molecule has been rotated 451 about the horizontal axis
(top to back) compared to Figure 1A.
Figure 2 Overall folds of Mnk kinases. Stereo ribbon plots of the Mnk kinases. The N-terminal lobes are shown in dark gray, the C-terminal
lobes in light gray. All structural figures were prepared with PyMol (http://pymol.sourceforge.net/). (A) Overall structure of Mnk1-KR. If not
mentioned otherwise, the same orientation of the kinase and the same relative orientations of other kinases are maintained in all following
figures. The coloring scheme for functional elements is the same as in Figure 1 and is maintained in the following figures: tip of the glycine-rich
loop (GR-loop)—cyan; Lys–Glu ion pair—magenta; helix aC—blue; catalytic loop (C-loop)—yellow; DFG/D motif—orange; activation
segment—green. The activation loop and the Pþ 1 loop (residues 197–222) and a Mnk-specific cysteine cluster and helix aG (residues
261–290) could not be modeled (terminal residues indicated). (B) Overall structure of Mnk2-KR (determined in Jauch et al, 2005) after
alignment of its C-terminal lobe on Mnk1-KR. Compared to Mnk1-KR, the N-terminal lobe of Mnk2-KR adopts an open conformation with
respect to the C-terminal lobe. The N-terminal portion of the activation segment (residues 232–250, Mnk2 numbering) could not be modeled
(terminal residues indicated). (C) Overall structure of the Mnk2-KRD228G–staurosporine complex after alignment of its C-terminal lobe on
Mnk1-KR. No pronounced global conformational changes are observed upon staurosporine binding compared to the apo-Mnk2-KR (B). The
N-terminal portion of the activation segment (residues 229–251, Mnk2 numbering) could not be modeled (terminal residues indicated).
(D) Stereo ribbon plot comparing Mnk1-KR (dark gray with helix aC in blue and the activation segment in green) with Mnk2-KR (lighter colors)
after superimposition via the C-terminal lobes, depicting the different relative orientations of the two lobes.
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Figure 4 ATP binding and DFG/D pockets. Stereo diagrams depicting details of the ATP and DFG/D pockets. Critical residues are labeled.
Hydrogen bonds and ionic interactions are depicted by dashed lines. (A) Mnk1-KR with an ionic interaction network involving the Asp residues
of the DFD motif. The conserved Lys–Glu ion pair is broken. The final 2FoFc electron density (gray; contoured at the 1s level) is shown
covering selected residues. (B) Mnk2-KR (Jauch et al, 2005) (PDB-ID 2AC3) in which the DFD-out conformation is retained, although the
activation segment has been detached from the N-terminal lobe. No clear interaction involving the Asp residues of the DFD motif can
be discerned. (C) DAPK1-Mn2þ–AMPPNP complex (Tereshko et al, 2001) (PDB ID 1IG1). The AMPPNP is shown in ball-and-stick (carbon—
brown; phosphorus—pink; Mn2þ—black sphere; water—blue spheres). (D) Mnk2–KRD228G–staurosporine complex. Staurosporine is shown in
ball-and-stick (carbon—brown). Note the complete reversal of the DFD-out to the DFD-in conformation upon staurosporine binding (compare
to panel B). The final 2Fo–Fc electron density (gray; contoured at the 1s level) is shown covering staurosporine and selected residues.
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4A, B). In the Mnk2-KR structure, the activation segment
protrudes from the kinase core and helix aF is prolonged by
one turn. Furthermore, Mnk2-KR displays an ordered Pþ 1
loop and a helical conformation in aEF, whereas these
QJ;elements are disordered (Pþ 1) or structurally rearranged
(helix aEF and aEF/aF loop) in Mnk1-KR. The N-terminal
lobe of Mnk2-KR is tilted by approximately 101 compared
to Mnk1-KR, leading to an opening of the ATP binding
mouth (Figures 2A and B) and explaining the absence
of acid–acid interactions involving the DFD motif in the
Mnk2-KR structure.
The conformation of Mnk2-KR in the crystal is stabilized
by extensive packing interactions involving the protruding
activation segment. In solution, Mnk2-KR may adopt a struc-
ture resembling Mnk1-KR. In order to investigate whether
Mnk1 and Mnk2 adopt similarly autoinhibited conformations
in solution, we determined relative nucleotide affinities of wt
and mutant enzymes.
Mutational analysis supports the mechanism of
autoinhibition in Mnks
ATP binding to nonphosphorylated Mnk1-KR appears to be
inhibited on two levels: (i) the Mnk-specific activation seg-
ment ‘locks’ the DFG/D-out conformation because Phe230
occupies the DFG/D-in pocket and (ii) the Mnk-specific Asp
of the DFD motif stabilizes the DFG/D-out conformation
by acid–acid interactions. We reasoned that this dual-level
control should be reflected in significantly higher nucleo-
tide affinities of the phosphorylated kinases compared to the
nonphosphorylated forms and intermediate affinities in non-
phosphorylated mutants lacking Phe230 or the Mnk-specific
DFD-Asp. We had previously tested ATP binding to phos-
phorylated and nonphosphorylated Mnk2-KR using a dot-blot
assay but were not able to determine relative affinities
(Jauch et al, 2005). We therefore employed the saturation
transfer difference (STD) NMR method to monitor magneti-
zation transfer from protein to bound AMPPNP, a nonhydro-
lyzable ATP analog. STD-NMR is a versatile and robust
screening method that selectively detects protein-bound
nucleotides for a wide range of affinities (McCoy et al,
2005). Although it is difficult to determine absolute Kd’s by
STD-NMR, the method can reliably detect relative affinities
even for low-affinity interactions as in the present case.
Nonphosphorylated Mnk1-KR only showed a very weak
STD signal, indicating that it bound only minute amounts
of AMPPNP (Figure 5). Interaction with the nucleotide was
significantly enhanced upon phosphorylation (Figure 5). As
expected, nonphosphorylated Mnk1-KR mutants, in which
insertion I2 (residues 228–232) had been deleted or in
which Phe230 was converted into an alanine, bound
AMPPNP at intermediate degrees (Figure 5). In each case,
bound AMPPNP could be released by the addition of staur-
osporine. Staurosporine is a nonspecific kinase inhibitor with
nanomolar to low micromolar Kd’s for most Ser/Thr kinases
that competes with ATP at its canonical binding site (Tamaoki
et al, 1986; Lawrie et al, 1997; Prade et al, 1997). Thus, all
AMPPNP binding detected occurred at the canonical ATP
pockets of the enzymes. These results support the role of
Phe230 and of the Mnk-specific insertion I2 in stabilizing the
ATP-competitive DFD-out conformation.
Nonphosphorylated Mnk2-KR exhibited higher residual
AMPPNP affinity than Mnk1-KR but once again nucleotide
binding was significantly enhanced upon phosphoryla-
tion (Figure 5). Again as expected, the affinity of AMPPNP
to the nonphosphorylated Mnk2-KRD228G mutant, in which
the DFD motif had been converted to a DFG motif, was
intermediate between that of nonphosphorylated and phos-
phorylated wt Mnk2-KR (Figure 5). Again staurosporine
competed with AMPPNP binding in each case (Figure 5A).
These findings are consistent with the Mnk-specific Asp of
the DFD motif (Asp228 in Mnk2) stabilizing the inhibitory
DFG/D-out conformation in Mnk2, in agreement with its
enrollment in acid–acid interactions as seen in Mnk1-KR.
The observation that conversion of the DFD to a DFG
motif does not fully restore the nucleotide affinity of the
phosphorylated wt enzyme is consistent with the idea
that the ATP-competitive conformation of Mnk2-KR in solu-
tion is reinforced by a Mnk1-KR-like repositioning of the
activation segment.
Different stringency of autoinhibition in Mnk1 and Mnk2
Nonphosphorylated Mnk2-KR exhibited higher residual
affinity to AMPPNP than nonphosphorylated Mnk1-KR
(Figure 5A, right panel). This observation suggests that the
activation segment in nonphosphorylated Mnk2-KR exhibits
conformational fluctuations that allow ATP to partially
‘squeeze’ into its binding site and reverse the inhibitory
DFD-out conformation, whereas nonphosphorylated Mnk1-
KR is more stringently controlled and adopts an ATP-recep-
tive conformation to a lesser extent. In order to explain these
differences, we used the Mnk1-KR structure as a scaffold and
converted all residues to the Mnk2 sequence. In the resulting
Mnk2-KR homology model, most intramolecular contacts
involving the repositioned activation segment were main-
tained by identical or highly homologous residues with two
exceptions: (i) in Mnk1-KR, the Tyr60 hydroxyl group hydro-
gen bonds to the backbone carbonyl of Asp193 (DFD motif)
and to the backbone amide of Val227 (neighboring insertion
I2) and thereby stabilizes the autoinhibitory conformation
(not shown). Mnk2 contains His95 at the respective position,
whose side chain may be less suited to engage in similar
interactions. (ii) The side chain of Thr97 of Mnk1-KR hydro-
gen bonds to the backbone carbonyls of Arg93 and Phe230. It
is replaced by Met132 in Mnk2, which cannot support similar
interactions and may weaken the alignment of the aEF-aEF/
aF loop region with helix aC. Taken together, our data
support the notion that Mnk1 and Mnk2 are regulated by a
fundamentally similar mechanism but that because of a few
amino-acid replacements autoinhibition is tighter in Mnk1
than in Mnk2. Our observation of a tighter autoinhibition in
Mnk1 agrees with the previous notion that Mnk2 exhibits
a higher basal activity compared to Mnk1 (Parra et al, 2005).
Staurosporine induces a DFG/D-in conformation after
unlocking
We next sought direct evidence for the hypothesis that the
Mnk2-KR crystal structure was unlocked with respect to the
inhibitory DFG/D-out conformation and that ATP binding
additionally demands a switch from the DFG/D-out to the
DFG/D-in conformation. To this end, we performed cocrys-
tallization and soaking experiments with ATP, AMPPNP or
staurosporine. Derivatizing Mnk1-KR or Mnk2-KR crystals
with any of the compounds by either technique failed.
For Mnk2-KRD228G, however, we were able to determine a
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staurosporine cocrystal structure at 2.7 A˚ resolution (Table I).
As expected, staurosporine binds at the canonical ATP pocket
in a fashion similar to its known binding mode in other PKs
(Lawrie et al, 1997; Prade et al, 1997) (Figures 2C and 4D).
The polycyclic ring system of the drug is sandwiched between
the b-sheet of the N-terminal lobe and the short two-stranded
b6–b7 sheet of the C-terminal lobe (Figure 4D). The N1 and
O5 atoms of staurosporine engage in hydrogen bonds to the
backbone carbonyl of Glu160 and the backbone nitrogen of
Met162 of the hinge region, respectively (Figure 4D). Similar
hydrogen bonds are fostered by the adenine base of ATP
when bound to PKs (Prade et al, 1997). Significantly, binding
of staurosporine elicited a complete switch of the DFG
motif from the DFG/D-out to the DFG/D-in conformation
(Figure 4D). The resulting conformation of Mnk2-KRD228G
provides a nucleotide-binding pocket, which could likewise
accept an ATP molecule. This observation indicates that
binding of ATP requires a similar switch of the DFD motif,
Figure 5 AMPPNP binding. (A) STD-NMR spectra of 0.6 mM AMPPNP (1.0 mM AMPPNP for Mnk1-KR, lower right) binding to 20 mm enzyme
covering the region of the strong NMR signals of H2 (8.22 p.p.m.) and H6 (6.10 p.p.m.) of AMPPNP. Left panel: spectra of Mnk1-KRs all
retaining the N-terminal GST tag. Right panel: spectra of Mnk1-KR and Mnk2-KRs without the tag. The top-right spectrum was recorded after
addition of 0.1 mM staurosporine to an NMR sample containing 2.0 mM AMPPNP and 20mM Mnk2-KRD228G. The negative peaks seen in this
spectrum were also seen in the spectrum of AMPPNP alone. Identical NMR parameters were used for each spectrum acquisition. (B) Fractional
STD effects (ISTD/Iref) of AMPPNP (H2 proton) in the presence of nonphosphorylated GST-Mnk1-KR, nonphosphorylated GST-Mnk1-KR
F230A,
nonphosphorylated GST-Mnk1-KRDI2, phosphorylated GST-Mnk1-KR, nonphosphorylated Mnk2-KR, nonphosphorylated Mnk2-KRD228G or
phosphorylated Mnk2-KR. The protein concentration was kept fixed (20mM) and the AMPPNP concentration was increased: 0.6 mM—white;
0.8 mM—light gray; 1.0 mM—gray. The fractional STD effect (ISTD/Iref) decreases with increasing excess of AMPPNP. Note that the trends in the
relative affinities are independent of the AMPPNP concentration. Maximum errors based on the signal-to-noise ratio are indicated.
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which in turn would require a previous removal of the Phe
residue of the activation segment from the DFG/D-in pocket.
Furthermore, these results suggest that binding of an ATP-
competitive substance and thus presumably of ATP at the
nucleotide-binding site is sufficient to induce the DFG/D-in
conformation after unlocking.
Discussion
Our results show that nonphosphorylated members of the
Mnk subfamily are autoinhibited by reprogramming of the
activation segment into an autoinhibitory module. Residues
in a Mnk-specific insertion (I2, located within the aEF/aF
loop) and in the unwound helix aEF interact with helix aC of
the N-terminal lobe and thereby disable canonical peptide
substrate positioning. Furthermore, the repositioned activa-
tion segment places a Phe from insertion I2 into the DFG/D-in
pocket, which locks the DFD motif in an ATP-competitive
DFG/D-out conformation.
Activation of Mnks involves phosphorylation at two sites
within the activation loop (Waskiewicz et al, 1999; Scheper
et al, 2001; Ueda et al, 2004). Phosphorylation most likely
provides alternative interaction sites for Arg residues that
stabilize the autoinhibited state. The residues to become
phosphorylated reside at the core of the activation segment,
which is disordered in the present Mnk1-KR structure and
thus presumably is accessible to the activating kinases.
Therefore, the repositioned activation segment not only
silences the enzymes but also presents phosphorylation
target residues to the activating kinases.
Interestingly, the receptor tyrosine kinases c-KIT (Mol et al,
2004b) and Flt3 (Griffith et al, 2004) also achieve autoinhibi-
tion by plunging a hydrophobic residue into the DFG/D-in
pocket and thereby reinforcing a DFG/D-out conformation
(Figure 3B). However, the blocking residue in c-KIT and Flt3
originates from a specialized autoinhibiton module, the jux-
tamembrane (JM) domain that connects a transmembrane
helix to the catalytic domain on the cytoplasmic side (Griffith
et al, 2004; Mol et al, 2004b). This JM domain lies outside the
kinase core as opposed to the situation in Mnks, in which the
blocking residue (Phe230/Phe265 in Mnk1/Mnk2) originates
from the activation segment.
Differences in the AMPPNP affinities of the nonphosphory-
lated Mnks suggest that the degree of autoinhibition may be
fine-tuned in the different isoforms. Intriguingly, the lower
residual AMPPNP affinity in nonphosphorylated Mnk1-KR
compared to nonphosphorylated Mnk2-KR correlates with a
lower basal activity of the Mnk1 isoform in cell culture assays
(Parra et al, 2005). It may be explained by a small number
of amino-acid substitutions as suggested by our homology
model. However, based on the overall trends of the differ-
ential nucleotide-binding analysis we expect that Mnk1 and
Mnk2 are regulated by a fundamentally similar mechanism.
Our crystal structures highlight conformational switches
required for Mnk activation (Figure 6). The structure of
Mnk1-KR represents the fully autoinhibited state (Figure
6,I). Before ATP can bind, the activation segment has to be
detached from the N-terminal lobe (unlocking). The structure
of Mnk2-KR delineates conformational changes accompany-
ing this relocation (II): the interlobal cleft opens up, Phe230/
Phe265 (Mnk1/Mnk2) is removed from the DFG/D-in pocket
and the Lys–Glu ion pair can be formed. In the absence of
ATP, the DFD motif may retain the DFG/D-out conformation
owing to the favorable interactions involving the Mnk-
specific DFD-Asp and torsional restraints. After unlocking,
ATP can bind and force the DFD-motif into the DFG/D-in
conformation, as inferred from the cocrystal structure of
Mnk2-KRD228G with staurosporine (III). To adopt the active
state, a further inward switch of the Pþ 1 loop and helix aEF
is required (Nolen et al, 2004). In the Mnk2-KR crystals, the
interactions between neighboring molecules involve the Pþ 1
loop and helix aEF and closely resemble the intramolecular
packing of these elements in active-state kinases (Jauch et al,
2005), thus allowing modeling of the active state (IV). We
further assume a reclosure of the interlobal cleft in the
active state, which would bring residues from the N-terminal
lobe such as the GR-loop and the Lys–Glu pair to their
catalytic positions.
Figure 6 Model for the mechanistic dynamics during Mnk activation. Schematics depicting structural changes required for Mnk activation.
The two lobes of the kinase domain are shown as ellipses. Functional elements are color-coded as before. I—autoinhibited state (based on the
Mnk1-KR structure); II—structural consequences upon detaching the activation segment from the N-terminal lobe (based on the Mnk2-KR
structure); III—DFG/D-in-to-out switch upon ATP binding (based on the Mnk2-KRD228G–staurosporine structure); IV—active state (model).
Regions of the activation segment that were disordered in the crystal structures are shown as dashed lines and in arbitrary conformations. The
activation segment of the active state (IV) has been modeled based on the crystal packing interaction involving the activation segment in the
Mnk2-KR structure (Jauch et al, 2005). II and III have been put in brackets because they may not be stable intermediates in vivo or the sequence
of structural changes may be different.
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The ensemble of Mnk structures suggests that the con-
formational switches required for Mnk activation (Figure 6)
can be fired in a stepwise fashion in vitro. However, in vivo
the conformational changes do not have to occur in precisely
the order depicted and do not necessarily involve stable
intermediates. For example, after phosphorylation, several
steps could occur concomitantly or positioning of the Pþ 1
loop and helix aEF at the C-terminal lobe and peptide sub-
strate binding could take place before ATP binding.
Finally, our observations have direct implications for the
design of Mnk-specific inhibitors. To date, the DFG/D-out con-
formation has been observed in only about 10% of the more
than 50 PKs for which structural data are available (Mol et al,
2004b; Vieth et al, 2005). In rare cases, the DFG/D-out con-
formation is adopted in the absence of ligands, as first seen in
IRK (Hubbard et al, 1994). More often it is induced or stabilized
by the binding of selective inhibitors such as in the structures
of p38 with Birb796 (Pargellis et al, 2002), c-Abl with Gleevec
(Nagar et al, 2002) and VEGFR-2 with AAL-993 (Manley et al,
2004). Inhibitors inducing the DFG/D-out conformation by
targeting the DFG/D-in pocket are expected to bind with higher
selectivity compared to classical compounds, which resemble
the binding mode of ATP (Mol et al, 2004b). In Mnks, the Phe
from the specific insertion I2 points out a selective binding
surface (the DFG/D-in pocket) that could be exploited for the
design of specific inhibitors. The selectivity of this site is further
enhanced by the Mnk-specific DFD-Asp in the vicinity.
Materials and methods
Cloning and protein preparation
A cDNA fragment encoding amino acids 37–341 of human Mnk1
was amplified using the forward/reverse primer pair 50-CGGGATCC
ACTGACTCCTTGCCAGGAAAG/50ACGCGTCGACCTATCCCTTTTCT
GGAGCTTGCC (restriction sites underlined) and was cloned into the
BamHI and SalI sites of vector pGEX-4T1 (Amersham Biosciences).
This construct allowed expression of Mnk1-KR in E. coli as a fusion
protein with a N-terminal, thrombin-cleavable glutathione S-transfer-
ase (GST) tag. Mutations to produce Mnk1-KR variants, in which
either Phe230 was converted to Ala (Mnk1-KRF230A) or in which
residues 228–232 were deleted (Mnk1-KRDI2), were introduced by the
QuikChange strategy (Stratagene). The expression and purification of
Mnk1-KR and Mnk1-KR variants were identical to the methods
described for Mnk2-KR and Mnk2-KRD228G (Jauch et al, 2005).
Crystallization and data collection
Wt Mnk1-KR was crystallized at 201C by vapor diffusion with a
reservoir solution containing 20% (w/v) PEG3350, 0.2 M ammo-
nium sulfate and 0.1 M Na-citrate, pH 5.6. Crystals were frozen in
a liquid nitrogen stream after transfer into reservoir solution
supplemented with 20% glycerol. Crystals of Mnk2-KRD228G were
grown as described previously (Jauch et al, 2005) and were soaked
for 24 h in a 300mM solution of staurosporine (Sigma-Aldrich) in
mother liquor supplemented with 5% (v/v) dimethylsulfoxide.
Soaked crystals were cryo-protected and frozen as the underivatized
variants (Jauch et al, 2005). Diffraction data for Mnk1-KR and
Mnk2-KRD228G–staurosporine (Table I) were collected at the PXI and
PXII beam lines of the Swiss Light Source (Villigen, Switzerland) at
100 K on a MarResearch CCD detector and processed with the HKL
package (Otwinowski and Minor, 1997) (Table I).
Structure solution and refinement
The Mnk1-KR structure was solved by molecular replacement
(Collaborative Computational Project, 1994) using a truncated
version of Mnk2-KR (Jauch et al, 2005) as the search model.
The initial electron density was modified by solvent flattening
and noncrystallographic symmetry (NCS) averaging (Collaborative
Computational Project, 1994). Model building was conducted
manually with COOT (Emsley and Cowtan, 2004). Refinement
was performed with CNS (Brunger et al, 1998) and Refmac5
(Collaborative Computational Project, 1994). Initially, refinement
made use of NCS restraints that were omitted in later cycles. All
data between 30.0 and 2.5 A˚ resolution were employed in the
refinement, setting aside 5% of the reflections to monitor the
free R-factor (Table I). The Rfree set was maintained upon
switching refinement programs. Monitoring data completeness in
0.1 A˚ resolution shells showed that the effective resolution of the
structure was 2.8 A˚. However, the density was further improved by
including all data up to 2.5 A˚ resolution in the refinement process.
The Mnk2-KRD228G–staurosporine cocrystal structure was solved
by molecular replacement using the Mnk2-KR coordinates. Model
building and refinement were conducted as for Mnk1-KR using all
data between 30.0 and 2.7 A˚ resolution and with 5% of the reflections
monitoring the free R-factor (Table I). Staurosporine was added
during later refinement cycles to a patch of FoFc difference electron
density that was already clearly defined at the onset of refinement.
NMR nucleotide binding assays
One-dimensional 1H spectra and STD-NMR spectra were recorded
at 301C on a Bruker Avance-600 spectrometer equipped with a
5 mm cryogenic probe head. NMR samples contained the respec-
tive enzyme (nonphosphorylated Mnk1-KR, nonphosphorylated
GST-Mnk1-KR, nonphosphorylated GST-Mnk1-KRF230A, nonphos-
phorylated GST-Mnk1-KRDI2, phosphorylated GST-Mnk1-KR,
nonphosphorylated Mnk2-KR, nonphosphorylated Mnk2-KRD228G
or phosphorylated Mnk2-KR) without or with AMPPNP (Sigma-
Aldrich, 95% purity). All NMR samples were prepared in 10 mM
Tris-d, 2 mM MgCl2, 100 mM NaCl, 1 mM dithiothreitol in 99.8%
D2O at pH 7.5 (uncorrected for isotope effects) and were adjusted to
a protein concentration of 20mM based on the absorption at 280 nm.
The concentration of AMPPNP was increased stepwise from 0.6 mM
to 1.0 mM, corresponding to protein:AMPPNP ratios of 1:30, 1:40,
1:50. At higher AMPPNP concentrations, partial aggregation of
AMPPNP was observed. At the end of the AMPPNP titration
staurosporine was added.
STD-NMR spectra were acquired using a series of 60 equally
spaced 50-ms Gaussian-shaped pulses for selective saturation with
a total duration of 3 s. The radiofrequency field strength for
the selective saturation pulses was 22 Hz. The frequencies of the
protein on-resonance and off-resonance saturation were set to 1.7
and 17 p.p.m., respectively. Similar results were obtained with
an on-resonance saturation frequency of 0.352 p.p.m. To suppress
residual protein signal, a T1r-filter comprising a spin lock pulse of
50 ms was applied. Using a recycle delay of 5 s and eight dummy
scans, 512 total scans were recorded for each experiment. NMR
spectra were multiplied by an exponential window function
with a 2.0 Hz line broadening factor before Fourier transformation.
Bruker Topspin v. 1.3 was used for processing and analysis of NMR
spectra. Fractional STD effects were evaluated as ISTD/Iref, in which
ISTD is the difference of the intensities of a signal in the on- and off-
resonance spectra, and Iref is the intensity of the corresponding
signal in the off-resonance spectrum (Mayer and Meyer, 2001).
Control experiments that resulted in no observable STD-NMR
signal included measuring (i) a sample of only AMPPNP at a
concentration of 1.5 mM and (ii) a sample of GST (not expected to
bind AMPPNP) and AMPPNP at a ratio of 1:50.
Data deposition
Coordinates and structure factors have been submitted to the RSCB
Protein Databank (http://www.rcsb.org/pdb/) with accession
codes 2HW6 (Mnk1-KR) and 2HW7 (Mnk2-KRD228G–staurosporine)
and will be released upon publication.
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